Karuna Therapeutics Inc
Change company Symbol lookup
Select an option...
KRTX Karuna Therapeutics Inc
BLUE bluebird bio Inc
ENSV Enservco Corp
ULIHF United Laboratories International Holdings Ltd
ABOIF Aboitiz Equity Ventures Inc
VYNE Vyne Therapeutics Inc
CEAD CEA Industries Inc
BFRI Biofrontera Inc
ARW Arrow Electronics Inc
SF-B Stifel Financial Corp
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Karuna Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on creating and delivering transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate, KarXT, is an oral modulator of muscarinic receptors that are located both in the central nervous system (CNS) and various peripheral tissues. It is initially developing KarXT, for the treatment of acute psychosis in patients with schizophrenia. The Company is for the treatment of psychosis in Alzheimer's disease (AD), which is the prevalent subtype of dementia-related psychosis (DRP). KarXT is a combination of xanomeline and trospium. It is advancing a pipeline of therapeutic programs to address the positive, negative and cognitive symptoms associated with schizophrenia and dementia-related psychosis (DRP). Its muscarinic receptors serve a number of physiological roles, including in cognitive, behavioral, sensory, motor and autonomic processes.

Price
Delayed
$131.25
Day's Change
5.15 (4.08%)
Bid
--
Ask
--
B/A Size
--
Day's High
131.39
Day's Low
123.70
Volume
(Light)

Today's volume of 201,168 shares is on pace to be much lighter than KRTX's 10-day average volume of 433,407 shares.

201,168
  • Prev Close
    126.10
  • Today's Open
    124.91
  • Day's Range
    123.70-131.39
  • Avg Vol (10-day)
    433.4K
  • Last (time)
    2:45p ET 07/05/22
  • Last (size)
    100
  • 52-Wk Range
    92.26 - 161.98
    LowHigh
  • (11/05/21 - 05/12/22)
    18.97%
  • 53.8%
  • Market Cap
    3.9B
  • Shares Outstanding
    29.9M
  • -5.78
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 99.01
  • (% of float 06/15/22)
    4.30

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.